SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-24-007958
Filing Date
2024-05-13
Accepted
2024-05-13 16:05:49
Documents
15
Period of Report
2024-05-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K capr-20240513x8k.htm   iXBRL 8-K 37824
2 EX-99.1 capr-20240513xex99d1.htm EX-99.1 130613
3 GRAPHIC capr-20240513xex99d1001.jpg GRAPHIC 5626
  Complete submission text file 0001558370-24-007958.txt   308072

Data Files

Seq Description Document Type Size
4 EX-101.SCH capr-20240513.xsd EX-101.SCH 3120
5 EX-101.LAB capr-20240513_lab.xml EX-101.LAB 15266
6 EX-101.PRE capr-20240513_pre.xml EX-101.PRE 9654
18 EXTRACTED XBRL INSTANCE DOCUMENT capr-20240513x8k_htm.xml XML 4682
Mailing Address 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA 90211
Business Address 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA 90211 (310) 358-3200
CAPRICOR THERAPEUTICS, INC. (Filer) CIK: 0001133869 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34058 | Film No.: 24938993
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)